Patent · US Active

Probiotic strains for use in treatment or prevention of osteoporosis

US10245290B2 · kind B2 · utility

0Cited by

0References

30Claims

0Family size

Assignee

PROBI AB · SE

Inventors

Anna Berggren · Flyinge, SE
Niklas Larsson · Lund, SE
Gunilla Önning · Höör, SE
Irini Lazou Ahrén · Lund, SE
Klara Sjögren · Åsa, SE
Claes Ohlsson · Mölndal, SE

Key dates

Filing date	Apr 3, 2014
Grant date	Apr 2, 2019
Priority date	—
Expiry date	Jul 19, 2034

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC12R2001/25
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention relates to at least one probiotic strain chosen from Lactobacillus paracasei, or at least one probiotic strain chosen from Lactobacillus paracaseiin combination with at least one probiotic strain chosen from Lactobacillus plantarum, for use in the treatment or prevention of osteoporosis or for use in increasing the absorption of at Ca2+ ions, in a mammal, preferably in a human.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.